Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Staphylococcus Aureus
100%
Azithromycin
100%
Macrolide Resistance
100%
Haemophilus Influenzae
36%
S. Pneumoniae
27%
Moraxella Catarrhalis
18%
Influenza Pneumonia
18%
Copenhagen
9%
Treatment Duration
9%
In(III)
9%
Low-dose Treatment
9%
Pseudomonas Aeruginosa (P. aeruginosa)
9%
Microorganisms
9%
Streptococcus Pneumoniae
9%
Microbiological Test
9%
Resistant Isolate
9%
Phage Type
9%
Macrolides
9%
Patient-led
9%
Resistant Strains
9%
Sputum Samples
9%
CF Center
9%
Clinically Insignificant
9%
Phage Typing
9%
Pharmacology, Toxicology and Pharmaceutical Science
Staphylococcus Aureus
100%
Macrolide
100%
Azithromycin
100%
Haemophilus influenzae
36%
Prevalence
27%
Bacteriophage
18%
Microorganism
9%
Pseudomonas aeruginosa
9%
Streptococcus Pneumoniae
9%
Methicillin-Resistant Staphylococcus Aureus
9%
Moraxella catarrhalis
9%
Immunology and Microbiology
Low Drug Dose
100%
Staphylococcus Aureus
100%
Haemophilus influenzae
36%
Prevalence
27%
Pneumococcus
27%
Pseudomonas aeruginosa
9%
Microorganism
9%
Sputum
9%
Moraxella catarrhalis
9%
Streptococcus Pneumoniae
9%
Bacteriophage
9%
Methicillin-Resistant Staphylococcus Aureus
9%
Phage Typing
9%